David Berglund - Publications

Early Postreperfusion Proteomics Reveal Divergent Inflammatory Responses in Kidney Transplantation With Implications on Outcomes.

Journal: Transplantation

Published: October 31, 2025

Renal Arterial Resistive Index Identifies Thrombotic Microangiopathy After Kidney Xenotransplantation in Pig-to-Baboon Model.

Journal: Xenotransplantation

Published: October 19, 2025

CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 19, 2024

Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes.

Journal: Kidney international reports

Published: July 18, 2023

Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 09, 2023

Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.

Journal: Frontiers in immunology

Published: August 27, 2020

Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent.

Journal: Frontiers in oncology

Published: August 24, 2020

Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro.

Journal: Frontiers in immunology

Published: August 07, 2020

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy.

Journal: EBioMedicine

Published: May 16, 2020

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.

Journal: Cancer immunology, immunotherapy : CII

Published: February 23, 2020

CD2 Immunobiology.

Journal: Frontiers in immunology

Published: February 06, 2020

Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis.

Journal: PloS one

Published: August 19, 2019